Daily Anesthesiology Research Analysis
Analyzed 87 papers and selected 3 impactful papers.
Summary
Three impactful anesthesiology-adjacent studies stood out: two mechanistic PNAS papers that clarify peripheral neural pathways of sedation and introduce a multi–sodium channel, nonopioid analgesic strategy, and a pediatric randomized trial showing low fresh gas flows reduce intraoperative hypothermia in neonates. Together, they advance mechanistic insight into sedative actions and perioperative analgesia while offering immediately actionable thermal management in neonatal anesthesia.
Research Themes
- Peripheral vagal mechanisms of sedative action
- Opioid-sparing perioperative analgesia via multi-target sodium channel blockade
- Thermoregulation strategy in neonatal anesthesia through low fresh gas flow
Selected Articles
1. Vagal nerve TRPV3 regulates sedative-mediated appeasement.
This mechanistic study identifies TRPV3 in nodose ganglion as a key peripheral sensor through which citronellal and sevoflurane attenuate stress responses via the vagal NG–cNTS glutamatergic pathway. Surgical vagotomy abolished these effects, establishing a causal vagal mechanism for sedative-mediated appeasement.
Impact: It reveals a peripheral, targetable mechanism for sedative effects, linking an inhaled anesthetic (sevoflurane) to vagal TRPV3 signaling. This opens avenues for anxiolysis and sedation strategies that leverage vagal pathways.
Clinical Implications: Suggests that modulating vagal TRPV3 could attenuate stress-related cardiopulmonary hyperactivity during perioperative care and may inform adjunctive nonpharmacologic or pharmacologic anxiolysis approaches.
Key Findings
- Citronellal reduced stress-related anxiety by modulating vagal tone via TRPV3 in nodose ganglion.
- TRPV3 mediated the antistress effects of sevoflurane on heart and respiratory rate hyperactivity.
- Effects required the NG-to-cNTS glutamatergic pathway and were abolished by surgical vagotomy.
Methodological Strengths
- Mechanistic dissection combining molecular target identification with intact pathway interrogation (NG–cNTS).
- Causal validation via surgical vagotomy and convergent pharmacologic manipulations.
Limitations
- Preclinical models; translational relevance and dosing paradigms in humans remain to be established.
- Scope focused on acute stress responses; effects on broader perioperative outcomes need evaluation.
Future Directions: Validate TRPV3–vagal modulation in human studies, quantify effects on perioperative anxiety and autonomic stability, and explore selective TRPV3 modulators as adjuncts to inhaled anesthetics.
Aromatic essential oils (EOs) exhibit anxiolytic properties, yet their neural and molecular mechanisms remain to be understood. Here, we found that citronellal, an EO derived from lemongrass, alleviates stress-related anxiety by modulating vagal tone. We identified transient receptor potential vanilloid 3 (TRPV3) channel in nodose ganglion (NG) as the molecular target of citronellal. TRPV3 was also observed to mediate the antistress effects of the inhaled anesthetic sevoflurane. Both sedatives attenuated acute restraint stress-induced hyperactivity of heart and breath rates via glutamatergic neurotransmission along NG-to-caudal nucleus tractus solitarius (cNTS) pathway. This effect was abolished by surgical vagotomy,
2. The identification of potent nonopioid analgesics and their potential for perioperative use.
Using AI-guided discovery, the authors developed multi-subtype sodium channel blockers that produced robust analgesia across rat pain models without opioid-like adverse effects. A surgical simulation supported perioperative feasibility, challenging the paradigm that high subtype selectivity is essential.
Impact: Proposes a clinically tractable, nonopioid analgesic strategy with perioperative potential by simultaneously targeting multiple sodium channel subtypes. This could reshape multimodal analgesia and reduce perioperative opioid exposure.
Clinical Implications: If translated to humans, multi-subtype sodium channel blockers could serve as potent opioid-sparing agents in perioperative pain pathways, potentially lowering PONV, respiratory depression, and dependence risks.
Key Findings
- AI-driven discovery yielded hits/leads that inhibit multiple analgesia-related sodium channel subtypes.
- Compounds showed robust analgesia across diverse rat pain models without opioid-typical adverse reactions.
- Perioperative potential was supported in a surgical simulation model, suggesting feasibility for acute pain.
Methodological Strengths
- Integrated AI-driven screening with rational, multi-target ion channel pharmacology.
- Cross-model validation of analgesia in vivo and perioperative simulation testing.
Limitations
- Preclinical animal data; human safety, PK/PD, and efficacy remain untested.
- Simultaneous multi-channel blockade may carry off-target risks requiring careful translational evaluation.
Future Directions: Advance to IND-enabling studies: cardiac safety (hERG), CNS off-target profiling, dose-ranging in large animals, and Phase 1/2 perioperative trials focusing on opioid-sparing endpoints.
Development of potent nonopioid analgesics (NOAs) has attracted great attentions from both academic and industrial worlds, aiming at replacing current opioid drugs in acute and chronic pain management. Among the diverse proposed pathways toward nonopioid analgesia, voltage-gated sodium channel stood out as one of the most promising targets in developing potent NOA. Diverging from the prevailing focus on highly subtype-selective blockers, we report here the access of potent analgesia via the simultaneous inhibition on multianalgesic-related sodium channel subtypes. Originated from AI-driven drug discovery and computer-aided drug design, the hit and lead compounds exhibited efficient inhibitory effect on analgesic-related sodium channel subtypes, robust analgesic effect in various rat models and no opioid-related adverse reactions. Furthermore, the potential of such a multi-subtype sodium channel blocker for perioperative use was validated through a surgical simulation.
3. Effect of Low Fresh Gas Flows on Intraoperative Hypothermia Among Neonates Undergoing Abdominal Surgeries: A Randomized Controlled Trial.
In a randomized trial of 160 neonates undergoing abdominal surgery, low fresh gas flow (1 L/min) reduced the incidence and burden of intraoperative hypothermia versus routine flow (2 L/min), with similar safety outcomes. Thermal benefits included smaller temperature drops and higher minimum core temperatures.
Impact: Provides immediately actionable evidence to optimize thermoregulation in one of the most vulnerable anesthesia populations—neonates—using a simple ventilator setting change.
Clinical Implications: Consider adopting 1 L/min low-flow anesthesia alongside standard warming measures to reduce intraoperative hypothermia and time under 36°C in neonatal abdominal surgery.
Key Findings
- Intraoperative hypothermia incidence was lower with 1 L/min vs 2 L/min (75% vs 90%; p=0.01).
- Smaller median core temperature drop with low-flow (0.80°C vs 1.20°C; p<0.001) and higher minimum core temperature (35.5°C vs 35.0°C; p<0.001).
- Percentage of surgical time under 36°C was reduced (50.3% vs 65.6%; p=0.003) with comparable safety outcomes.
Methodological Strengths
- Prospective randomized controlled design with continuous intraoperative core temperature monitoring.
- Pre-specified primary and secondary endpoints with adequate sample size (n=160).
Limitations
- Single-center design may limit generalizability and did not assess longer-term outcomes.
- Despite benefits, hypothermia remained common, indicating need for multimodal warming strategies.
Future Directions: Multicenter trials integrating low-flow with multimodal warming and exploring neurodevelopmental and infection outcomes; evaluate optimal flow thresholds across surgical types.
INTRODUCTION: Intraoperative hypothermia remains a frequent and under-recognized complication in neonates undergoing surgery despite standard preventive measures. Low-flow anesthesia, by increasing rebreathing and conserving heat and humidity, may offer a thermo-protective effect. In this study, we compare the incidence of intraoperative hypothermia between low-flow (1 L/min) vs. routine-flow (2 L/min) anesthesia in neonates undergoing abdominal surgery. METHODS: After obtaining written informed consent from parents or legal guardians, 160 neonates scheduled for elective or emergency abdominal surgery were randomized into two groups: Group L (low-flow, 1 L/min) and Group C (control, 2 L/min). Core temperature was continuously monitored intraoperatively. The primary outcome was the incidence of intraoperative hypothermia (core temperature < 36°C). Secondary outcomes included changes in core temperature, minimum and maximum intraoperative temperature, percentage of surgical time spent under hypothermia, time to extubation, blood loss, transfusion requirements, use of inotropes, and postoperative ventilation. RESULTS: The incidence of intraoperative hypothermia was significantly lower in group L compared to group C (75% vs. 90%, p = 0.01). The median (IQR) drop in core temperature from baseline was smaller in group L as compared to group C [0.80°C (0.60-1.10) vs. 1.20°C (0.90-1.50), p < 0.001]. Minimum core temperature was higher in group L [35.5°C (35.20-35.90) vs. 35°C (34.80-35.40), p < 0.001]. The percentage of surgical time spent under hypothermia (< 36°C) was significantly lower in group L [50.3% (95% CI: 43.3-57.3)] compared to group C [65.6% (95% CI: 58.6-72.6), p = 0.003]. While intraoperative blood loss was slightly higher in the low-flow group, the clinical impact was minimal. Other outcomes, including extubation time, inotrope use, and hypoxia incidence, were comparable between groups. CONCLUSION: Low-flow anesthesia technique at 1 L/min is a safe and effective approach for reducing the incidence and duration of intraoperative hypothermia in neonates undergoing abdominal surgery.